|
autonomic nervous system development
|
GO:0048483 |
19 |
0.983
|
|
|
regulation of nucleic acid templated transcription
|
GO:1903506 |
213 |
0.973
|
|
|
regulation of nitrogen compound metabolic process
|
GO:0051171 |
251 |
0.962
|
|
|
sympathetic nervous system development
|
GO:0048485 |
3 |
0.955
|
|
|
neural crest cell migration
|
GO:0001755 |
42 |
0.943
|
|
|
biosynthetic process
|
GO:0009058 |
294 |
0.943
|
|
|
nucleobase containing compound biosynthetic process
|
GO:0034654 |
205 |
0.936
|
|
|
regulation of cellular metabolic process
|
GO:0031323 |
320 |
0.928
|
|
|
sympathetic ganglion development
|
GO:0061549 |
2 |
0.922
|
|
|
cellular aromatic compound metabolic process
|
GO:0006725 |
295 |
0.921
|
|
|
regulation of gene expression
|
GO:0010468 |
265 |
0.914
|
|
|
regulation of transcription dna templated
|
GO:0006355 |
213 |
0.892
|
|
|
mesenchymal cell development
|
GO:0014031 |
78 |
0.884
|
|
|
regulation of biosynthetic process
|
GO:0009889 |
250 |
0.875
|
|
|
rna biosynthetic process
|
GO:0032774 |
181 |
0.863
|
|
|
cellular biosynthetic process
|
GO:0044249 |
286 |
0.857
|
|
|
nitrogen compound metabolic process
|
GO:0006807 |
319 |
0.854
|
|
|
organic cyclic compound metabolic process
|
GO:1901360 |
301 |
0.854
|
|
|
neural crest cell development
|
GO:0014032 |
62 |
0.834
|
|
|
locomotion
|
GO:0040011 |
313 |
0.819
|
|
|
regulation of rna biosynthetic process
|
GO:2001141 |
213 |
0.818
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
74 |
0.804
|
|
|
developmental pigmentation
|
GO:0048066 |
48 |
0.802
|
|
|
cellular nitrogen compound biosynthetic process
|
GO:0044271 |
218 |
0.766
|
|
|
nucleobase containing compound metabolic process
|
GO:0006139 |
274 |
0.765
|
|
|
regulation of rna metabolic process
|
GO:0051252 |
224 |
0.760
|
|
|
pigment cell differentiation
|
GO:0050931 |
38 |
0.728
|
|
|
enteric nervous system development
|
GO:0048484 |
12 |
0.701
|
|
|
regulation of multicellular organismal development
|
GO:2000026 |
223 |
0.697
|
|
|
aromatic compound biosynthetic process
|
GO:0019438 |
217 |
0.696
|
|
|
regionalization
|
GO:0003002 |
274 |
0.687
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
87 |
0.650
|
|
|
neural crest cell differentiation
|
GO:0014033 |
72 |
0.650
|
|
|
cell morphogenesis involved in neuron differentiation
|
GO:0048667 |
163 |
0.647
|
|
|
axonogenesis
|
GO:0007409 |
152 |
0.623
|
|
|
regulation of transcription from rna polymerase ii promoter
|
GO:0006357 |
114 |
0.615
|
|
|
cellular nitrogen compound metabolic process
|
GO:0034641 |
290 |
0.611
|
|
|
regulation of metabolic process
|
GO:0019222 |
359 |
0.607
|
|
|
cellular macromolecule biosynthetic process
|
GO:0034645 |
224 |
0.604
|
|
|
axon guidance
|
GO:0007411 |
86 |
0.600
|
|
|
regulation of macromolecule metabolic process
|
GO:0060255 |
317 |
0.599
|
|
|
preganglionic parasympathetic nervous system development
|
GO:0021783 |
6 |
0.592
|
|
|
mesenchyme development
|
GO:0060485 |
127 |
0.587
|
|
|
central nervous system development
|
GO:0007417 |
387 |
0.584
|
|
|
regulation of cellular biosynthetic process
|
GO:0031326 |
245 |
0.582
|
|
|
organic substance biosynthetic process
|
GO:1901576 |
289 |
0.546
|
|
|
otic placode formation
|
GO:0043049 |
23 |
0.511
|
|
|
cellular component movement
|
GO:0006928 |
335 |
0.498
|
|
|
facial nerve morphogenesis
|
GO:0021610 |
1 |
0.495
|
|
|
cranial nerve development
|
GO:0021545 |
42 |
0.489
|
|
|
cellular macromolecule metabolic process
|
GO:0044260 |
391 |
0.476
|
|
|
nucleic acid templated transcription
|
GO:0097659 |
181 |
0.475
|
|
|
organic cyclic compound biosynthetic process
|
GO:1901362 |
223 |
0.469
|
|
|
localization of cell
|
GO:0051674 |
244 |
0.465
|
|
|
neuron projection morphogenesis
|
GO:0048812 |
161 |
0.464
|
|
|
organonitrogen compound metabolic process
|
GO:1901564 |
74 |
0.455
|
|
|
nucleic acid metabolic process
|
GO:0090304 |
244 |
0.453
|
|
|
regulation of primary metabolic process
|
GO:0080090 |
311 |
0.449
|
|
|
forebrain cell migration
|
GO:0021885 |
1 |
0.447
|
|
|
positive regulation of biological process
|
GO:0048518 |
253 |
0.442
|
|
|
axon development
|
GO:0061564 |
166 |
0.428
|
|
|
axon extension
|
GO:0048675 |
45 |
0.416
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
274 |
0.416
|
|
|
eye development
|
GO:0001654 |
277 |
0.414
|
|
|
rhombomere 6 development
|
GO:0021572 |
4 |
0.398
|
|
|
regulation of response to stimulus
|
GO:0048583 |
269 |
0.397
|
|
|
heterocycle metabolic process
|
GO:0046483 |
290 |
0.389
|
|
|
immune system development
|
GO:0002520 |
191 |
0.388
|
|
|
transcription dna templated
|
GO:0006351 |
181 |
0.382
|
|
|
stem cell development
|
GO:0048864 |
82 |
0.376
|
|
|
facial nerve development
|
GO:0021561 |
3 |
0.373
|
|
|
transcription from rna polymerase ii promoter
|
GO:0006366 |
80 |
0.369
|
|
|
cranial ganglion development
|
GO:0061550 |
3 |
0.366
|
|
|
neuron fate commitment
|
GO:0048663 |
26 |
0.352
|
|
|
cranial nerve morphogenesis
|
GO:0021602 |
15 |
0.352
|
|
|
regulation of macromolecule biosynthetic process
|
GO:0010556 |
225 |
0.350
|
|
|
regulation of cellular macromolecule biosynthetic process
|
GO:2000112 |
222 |
0.333
|
|
|
stem cell differentiation
|
GO:0048863 |
117 |
0.328
|
|
|
connective tissue development
|
GO:0061448 |
99 |
0.326
|
|
|
cartilage development
|
GO:0051216 |
96 |
0.318
|
|
|
otic vesicle development
|
GO:0071599 |
42 |
0.302
|
|
|
chemotaxis
|
GO:0006935 |
104 |
0.301
|
|
|
neuron projection guidance
|
GO:0097485 |
86 |
0.294
|
|
|
skeletal muscle organ development
|
GO:0060538 |
78 |
0.294
|
|
|
organelle organization
|
GO:0006996 |
227 |
0.286
|
|
|
regulation of multicellular organismal process
|
GO:0051239 |
277 |
0.282
|
|
|
cell morphogenesis involved in differentiation
|
GO:0000904 |
195 |
0.278
|
|
|
central nervous system myelination
|
GO:0022010 |
2 |
0.274
|
|
|
cell surface receptor signaling pathway
|
GO:0007166 |
325 |
0.272
|
|
|
tube morphogenesis
|
GO:0035239 |
349 |
0.268
|
|
|
generation of neurons
|
GO:0048699 |
385 |
0.266
|
|
|
ear morphogenesis
|
GO:0042471 |
64 |
0.265
|
|
|
embryonic organ development
|
GO:0048568 |
381 |
0.262
|
|
|
lateral line nerve glial cell development
|
GO:0048937 |
6 |
0.261
|
|
|
cell morphogenesis
|
GO:0000902 |
289 |
0.260
|
|
|
fin development
|
GO:0033333 |
77 |
0.260
|
|
|
regulation of cell differentiation
|
GO:0045595 |
142 |
0.256
|
|
|
gene expression
|
GO:0010467 |
252 |
0.248
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
148 |
0.241
|
|
|
inner ear morphogenesis
|
GO:0042472 |
63 |
0.239
|
|
|
negative regulation of biological process
|
GO:0048519 |
304 |
0.231
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
93 |
0.231
|
|
|
regulation of nucleobase containing compound metabolic process
|
GO:0019219 |
250 |
0.229
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
42 |
0.228
|
|
|
spinal cord development
|
GO:0021510 |
46 |
0.226
|
|
|
regulation of signaling
|
GO:0023051 |
235 |
0.222
|
|
|
nerve development
|
GO:0021675 |
45 |
0.222
|
|
|
neuron development
|
GO:0048666 |
262 |
0.217
|
|
|
cell fate commitment
|
GO:0045165 |
99 |
0.216
|
|
|
catecholamine biosynthetic process
|
GO:0042423 |
2 |
0.215
|
|
|
regulation of cell communication
|
GO:0010646 |
232 |
0.210
|
|
|
positive regulation of cellular process
|
GO:0048522 |
201 |
0.207
|
|
|
dorsal ventral pattern formation
|
GO:0009953 |
125 |
0.207
|
|
|
cell projection morphogenesis
|
GO:0048858 |
244 |
0.204
|
|
|
regulation of axon guidance
|
GO:1902667 |
8 |
0.195
|
|
|
muscle organ development
|
GO:0007517 |
101 |
0.195
|
|
|
otic vesicle morphogenesis
|
GO:0071600 |
34 |
0.192
|
|
|
anatomical structure arrangement
|
GO:0048532 |
2 |
0.191
|
|
|
positive regulation of response to stimulus
|
GO:0048584 |
80 |
0.190
|
|
|
epidermal cell differentiation
|
GO:0009913 |
36 |
0.188
|
|
|
branchiomotor neuron axon guidance
|
GO:0021785 |
1 |
0.186
|
|
|
axon extension involved in axon guidance
|
GO:0048846 |
10 |
0.185
|
|
|
cell part morphogenesis
|
GO:0032990 |
246 |
0.185
|
|
|
ectodermal placode formation
|
GO:0060788 |
26 |
0.184
|
|
|
negative regulation of cell communication
|
GO:0010648 |
96 |
0.181
|
|
|
embryonic cranial skeleton morphogenesis
|
GO:0048701 |
90 |
0.180
|
|
|
regulation of axon extension
|
GO:0030516 |
24 |
0.178
|
|
|
ectodermal placode development
|
GO:0071696 |
37 |
0.176
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
3 |
0.171
|
|
|
negative regulation of axonogenesis
|
GO:0050771 |
7 |
0.170
|
|
|
cell projection organization
|
GO:0030030 |
284 |
0.169
|
|
|
gliogenesis
|
GO:0042063 |
45 |
0.167
|
|
|
cell migration in hindbrain
|
GO:0021535 |
7 |
0.166
|
|
|
heterocycle biosynthetic process
|
GO:0018130 |
215 |
0.165
|
|
|
neuron migration
|
GO:0001764 |
22 |
0.164
|
|
|
anterior posterior pattern specification
|
GO:0009952 |
152 |
0.164
|
|
|
skin development
|
GO:0043588 |
54 |
0.163
|
|
|
chordate embryonic development
|
GO:0043009 |
271 |
0.160
|
|
|
rna metabolic process
|
GO:0016070 |
219 |
0.158
|
|
|
cell migration involved in heart development
|
GO:0060973 |
22 |
0.156
|
|
|
positive regulation of transport
|
GO:0051050 |
2 |
0.155
|
|
|
muscle tissue development
|
GO:0060537 |
110 |
0.154
|
|
|
cell migration
|
GO:0016477 |
237 |
0.150
|
|
|
neuron differentiation
|
GO:0030182 |
353 |
0.148
|
|
|
negative regulation of response to stimulus
|
GO:0048585 |
104 |
0.148
|
|
|
cell motility
|
GO:0048870 |
244 |
0.148
|
|
|
positive regulation of nitrogen compound metabolic process
|
GO:0051173 |
69 |
0.147
|
|
|
neuron projection development
|
GO:0031175 |
180 |
0.146
|
|
|
taxis
|
GO:0042330 |
109 |
0.146
|
|
|
cell fate specification
|
GO:0001708 |
68 |
0.144
|
|
|
hemopoiesis
|
GO:0030097 |
183 |
0.143
|
|
|
negative regulation of nitrogen compound metabolic process
|
GO:0051172 |
59 |
0.140
|
|
|
head development
|
GO:0060322 |
303 |
0.140
|
|
|
cell growth
|
GO:0016049 |
57 |
0.138
|
|
|
enzyme linked receptor protein signaling pathway
|
GO:0007167 |
106 |
0.138
|
|
|
regulation of cell death
|
GO:0010941 |
103 |
0.137
|
|
|
positive regulation of nucleobase containing compound metabolic process
|
GO:0045935 |
69 |
0.136
|
|
|
ectodermal placode morphogenesis
|
GO:0071697 |
32 |
0.136
|
|
|
response to stress
|
GO:0006950 |
263 |
0.135
|
|
|
signal transduction
|
GO:0007165 |
455 |
0.134
|
|
|
macromolecule biosynthetic process
|
GO:0009059 |
227 |
0.133
|
|
|
embryo development ending in birth or egg hatching
|
GO:0009792 |
271 |
0.131
|
|
|
pons development
|
GO:0021548 |
11 |
0.130
|
|
|
embryonic viscerocranium morphogenesis
|
GO:0048703 |
52 |
0.129
|
|
|
cellular amine metabolic process
|
GO:0044106 |
2 |
0.127
|
|
|
periodic partitioning
|
GO:0007365 |
1 |
0.127
|
|
|
organic acid metabolic process
|
GO:0006082 |
31 |
0.125
|
|
|
striated muscle tissue development
|
GO:0014706 |
110 |
0.124
|
|
|
pectoral fin development
|
GO:0033339 |
50 |
0.121
|
|
|
negative regulation of nucleobase containing compound metabolic process
|
GO:0045934 |
59 |
0.121
|
|
|
brain development
|
GO:0007420 |
293 |
0.120
|
|
|
ear development
|
GO:0043583 |
127 |
0.119
|
|
|
protein acetylation
|
GO:0006473 |
2 |
0.119
|
|
|
trigeminal nerve development
|
GO:0021559 |
3 |
0.119
|
|
|
embryonic skeletal system development
|
GO:0048706 |
97 |
0.116
|
|
|
segment polarity determination
|
GO:0007367 |
1 |
0.111
|
|
|
xanthophore differentiation
|
GO:0050936 |
3 |
0.110
|
|
|
response to nicotine
|
GO:0035094 |
2 |
0.109
|
|
|
response to chemical
|
GO:0042221 |
320 |
0.108
|
|
|
catecholamine metabolic process
|
GO:0006584 |
2 |
0.107
|
|
|
regulation of programmed cell death
|
GO:0043067 |
101 |
0.105
|
|
|
establishment of localization
|
GO:0051234 |
244 |
0.103
|
|
|
negative regulation of signaling
|
GO:0023057 |
96 |
0.103
|
|
|
amine metabolic process
|
GO:0009308 |
2 |
0.102
|
|
|
epithelial cell differentiation
|
GO:0030855 |
116 |
0.101
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
7 |
0.101
|
|
|
oligodendrocyte differentiation
|
GO:0048709 |
23 |
0.101
|
|
|
hematopoietic or lymphoid organ development
|
GO:0048534 |
191 |
0.100
|
|
|
regulation of axonogenesis
|
GO:0050770 |
32 |
0.099
|
|
|
developmental growth
|
GO:0048589 |
166 |
0.098
|
|
|
otic vesicle formation
|
GO:0030916 |
27 |
0.097
|
|
|
small molecule metabolic process
|
GO:0044281 |
77 |
0.097
|
|
|
ganglion development
|
GO:0061548 |
5 |
0.095
|
|
|
metencephalon development
|
GO:0022037 |
27 |
0.094
|
|
|
lens development in camera type eye
|
GO:0002088 |
22 |
0.093
|
|
|
neuron fate specification
|
GO:0048665 |
20 |
0.092
|
|
|
circulatory system process
|
GO:0003013 |
87 |
0.092
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
86 |
0.090
|
|
|
protein metabolic process
|
GO:0019538 |
183 |
0.090
|
|
|
stem cell division
|
GO:0017145 |
1 |
0.090
|
|
|
response to external stimulus
|
GO:0009605 |
264 |
0.089
|
|
|
neuroblast proliferation
|
GO:0007405 |
2 |
0.084
|
|
|
angiogenesis
|
GO:0001525 |
158 |
0.084
|
|
|
glial cell fate commitment
|
GO:0021781 |
6 |
0.084
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
10 |
0.081
|
|
|
single organism localization
|
GO:1902578 |
225 |
0.081
|
|
|
telencephalon development
|
GO:0021537 |
14 |
0.081
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
4 |
0.081
|
|
|
negative regulation of multicellular organismal process
|
GO:0051241 |
69 |
0.079
|
|
|
multicellular organism reproduction
|
GO:0032504 |
35 |
0.079
|
|
|
intracellular signal transduction
|
GO:0035556 |
85 |
0.079
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
200 |
0.077
|
|
|
digestive tract development
|
GO:0048565 |
265 |
0.076
|
|
|
skeletal muscle tissue development
|
GO:0007519 |
67 |
0.073
|
|
|
negative regulation of sequence specific dna binding transcription factor activity
|
GO:0043433 |
2 |
0.073
|
|
|
cellular response to vascular endothelial growth factor stimulus
|
GO:0035924 |
3 |
0.073
|
|
|
regulation of apoptotic process
|
GO:0042981 |
98 |
0.072
|
|
|
negative regulation of macromolecule metabolic process
|
GO:0010605 |
76 |
0.072
|
|
|
positive regulation of macromolecule metabolic process
|
GO:0010604 |
93 |
0.072
|
|
|
retina development in camera type eye
|
GO:0060041 |
146 |
0.071
|
|
|
response to organic substance
|
GO:0010033 |
153 |
0.070
|
|
|
inner ear development
|
GO:0048839 |
126 |
0.069
|
|
|
regulation of skeletal muscle cell differentiation
|
GO:2001014 |
1 |
0.069
|
|
|
regulation of cellular protein metabolic process
|
GO:0032268 |
52 |
0.069
|
|
|
parasympathetic nervous system development
|
GO:0048486 |
6 |
0.067
|
|
|
oxoacid metabolic process
|
GO:0043436 |
31 |
0.066
|
|
|
dopamine biosynthetic process
|
GO:0042416 |
2 |
0.065
|
|
|
pigmentation
|
GO:0043473 |
85 |
0.065
|
|
|
skeletal system development
|
GO:0001501 |
181 |
0.065
|
|
|
regulation of protein metabolic process
|
GO:0051246 |
56 |
0.065
|
|
|
cellular component assembly
|
GO:0022607 |
170 |
0.065
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
56 |
0.064
|
|
|
positive regulation of transcription dna templated
|
GO:0045893 |
57 |
0.064
|
|
|
multi organism process
|
GO:0051704 |
134 |
0.063
|
|
|
inositol lipid mediated signaling
|
GO:0048017 |
2 |
0.063
|
|
|
digestive system development
|
GO:0055123 |
289 |
0.061
|
|
|
axon ensheathment in central nervous system
|
GO:0032291 |
2 |
0.061
|
|
|
positive regulation of rna biosynthetic process
|
GO:1902680 |
57 |
0.061
|
|
|
positive regulation of cellular metabolic process
|
GO:0031325 |
94 |
0.061
|
|
|
immune system process
|
GO:0002376 |
241 |
0.060
|
|
|
death
|
GO:0016265 |
121 |
0.059
|
|
|
ameboidal type cell migration
|
GO:0001667 |
143 |
0.059
|
|
|
regulation of neurogenesis
|
GO:0050767 |
87 |
0.059
|
|
|
hypothalamus cell differentiation
|
GO:0021979 |
4 |
0.057
|
|
|
cellular protein metabolic process
|
GO:0044267 |
129 |
0.057
|
|
|
vasculature development
|
GO:0001944 |
278 |
0.057
|
|
|
negative regulation of neuron projection development
|
GO:0010977 |
9 |
0.056
|
|
|
regulation of signal transduction
|
GO:0009966 |
225 |
0.056
|
|
|
forebrain development
|
GO:0030900 |
96 |
0.055
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
0 |
0.055
|
|
|
neuroblast fate commitment
|
GO:0014017 |
1 |
0.054
|
|
|
behavior
|
GO:0007610 |
74 |
0.054
|
|
|
chromosome organization
|
GO:0051276 |
31 |
0.054
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
102 |
0.054
|
|
|
single organism metabolic process
|
GO:0044710 |
217 |
0.054
|
|
|
mitotic cell cycle
|
GO:0000278 |
64 |
0.054
|
|
|
cellular protein catabolic process
|
GO:0044257 |
4 |
0.052
|
|
|
regulation of developmental process
|
GO:0050793 |
247 |
0.052
|
|
|
regulation of anatomical structure morphogenesis
|
GO:0022603 |
130 |
0.051
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
29 |
0.051
|
|
|
growth plate cartilage morphogenesis
|
GO:0003422 |
1 |
0.051
|
|
|
axis specification
|
GO:0009798 |
43 |
0.050
|
|
|
regulation of tube size
|
GO:0035150 |
2 |
0.050
|
|
|
negative regulation of cellular process
|
GO:0048523 |
283 |
0.049
|
|
|
cell proliferation
|
GO:0008283 |
80 |
0.048
|
|
|
glial cell differentiation
|
GO:0010001 |
42 |
0.048
|
|
|
central nervous system myelin formation
|
GO:0032289 |
1 |
0.047
|
|
|
negative regulation of neurogenesis
|
GO:0050768 |
20 |
0.047
|
|
|
cellular component morphogenesis
|
GO:0032989 |
336 |
0.046
|
|
|
ventral spinal cord development
|
GO:0021517 |
35 |
0.046
|
|
|
stem cell fate commitment
|
GO:0048865 |
1 |
0.046
|
|
|
maintenance of location
|
GO:0051235 |
4 |
0.046
|
|
|
negative regulation of nucleic acid templated transcription
|
GO:1903507 |
45 |
0.046
|
|
|
neural tube development
|
GO:0021915 |
62 |
0.046
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
33 |
0.045
|
|
|
motor neuron axon guidance
|
GO:0008045 |
23 |
0.045
|
|
|
cell death
|
GO:0008219 |
121 |
0.045
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
4 |
0.044
|
|
|
gland development
|
GO:0048732 |
143 |
0.044
|
|
|
negative regulation of metabolic process
|
GO:0009892 |
86 |
0.044
|
|
|
cell differentiation in spinal cord
|
GO:0021515 |
40 |
0.044
|
|
|
tissue remodeling
|
GO:0048771 |
4 |
0.044
|
|
|
locus ceruleus development
|
GO:0021703 |
3 |
0.043
|
|
|
establishment of cell polarity
|
GO:0030010 |
18 |
0.043
|
|
|
positive regulation of nucleic acid templated transcription
|
GO:1903508 |
57 |
0.042
|
|
|
sensory organ development
|
GO:0007423 |
393 |
0.042
|
|
|
cellular response to organic substance
|
GO:0071310 |
105 |
0.042
|
|
|
transport
|
GO:0006810 |
220 |
0.041
|
|
|
negative regulation of developmental process
|
GO:0051093 |
65 |
0.041
|
|
|
positive regulation of rna metabolic process
|
GO:0051254 |
59 |
0.041
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
7 |
0.040
|
|
|
regulation of mapk cascade
|
GO:0043408 |
14 |
0.040
|
|
|
negative regulation of gene expression
|
GO:0010629 |
65 |
0.039
|
|
|
response to endogenous stimulus
|
GO:0009719 |
83 |
0.039
|
|
|
response to light stimulus
|
GO:0009416 |
46 |
0.039
|
|
|
organophosphate metabolic process
|
GO:0019637 |
37 |
0.038
|
|
|
macromolecular complex subunit organization
|
GO:0043933 |
74 |
0.038
|
|
|
negative regulation of macromolecule biosynthetic process
|
GO:0010558 |
48 |
0.037
|
|
|
embryonic pattern specification
|
GO:0009880 |
44 |
0.037
|
|
|
auditory receptor cell fate commitment
|
GO:0009912 |
4 |
0.037
|
|
|
single organism reproductive process
|
GO:0044702 |
40 |
0.036
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
27 |
0.036
|
|
|
epithelial tube formation
|
GO:0072175 |
19 |
0.036
|
|
|
epidermal cell fate specification
|
GO:0009957 |
4 |
0.036
|
|
|
lateral line ganglion development
|
GO:0048890 |
2 |
0.035
|
|
|
catechol containing compound biosynthetic process
|
GO:0009713 |
2 |
0.035
|
|
|
regulation of biological quality
|
GO:0065008 |
263 |
0.035
|
|
|
adult behavior
|
GO:0030534 |
2 |
0.035
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
23 |
0.035
|
|
|
negative regulation of cell development
|
GO:0010721 |
26 |
0.035
|
|
|
apoptotic process
|
GO:0006915 |
116 |
0.035
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
0 |
0.034
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
3 |
0.034
|
|
|
positive regulation of gene expression
|
GO:0010628 |
71 |
0.034
|
|
|
negative regulation of programmed cell death
|
GO:0043069 |
58 |
0.034
|
|
|
posterior lateral line nerve glial cell differentiation
|
GO:0048931 |
5 |
0.034
|
|
|
neural crest formation
|
GO:0014029 |
14 |
0.033
|
|
|
positive regulation of peptidyl tyrosine phosphorylation
|
GO:0050731 |
1 |
0.033
|
|
|
regulation of mesoderm development
|
GO:2000380 |
11 |
0.033
|
|
|
extrinsic apoptotic signaling pathway in absence of ligand
|
GO:0097192 |
1 |
0.032
|
|
|
regulation of blood vessel size
|
GO:0050880 |
2 |
0.032
|
|
|
regulation of nervous system development
|
GO:0051960 |
90 |
0.032
|
|
|
blood vessel development
|
GO:0001568 |
246 |
0.032
|
|
|
macromolecule modification
|
GO:0043412 |
111 |
0.032
|
|
|
camera type eye development
|
GO:0043010 |
222 |
0.032
|
|
|
negative regulation of cellular macromolecule biosynthetic process
|
GO:2000113 |
48 |
0.032
|
|
|
renal system development
|
GO:0072001 |
94 |
0.031
|
|
|
smooth muscle contraction
|
GO:0006939 |
2 |
0.031
|
|
|
peptide metabolic process
|
GO:0006518 |
1 |
0.031
|
|
|
negative chemotaxis
|
GO:0050919 |
1 |
0.031
|
|
|
positive regulation of axon guidance
|
GO:1902669 |
1 |
0.030
|
|
|
positive regulation of developmental process
|
GO:0051094 |
50 |
0.030
|
|
|
positive regulation of erk1 and erk2 cascade
|
GO:0070374 |
2 |
0.030
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
231 |
0.029
|
|
|
positive regulation of neurogenesis
|
GO:0050769 |
24 |
0.029
|
|
|
hindbrain development
|
GO:0030902 |
91 |
0.029
|
|
|
negative regulation of cell death
|
GO:0060548 |
60 |
0.029
|
|
|
cellular response to chemical stimulus
|
GO:0070887 |
157 |
0.028
|
|
|
morphogenesis of an epithelium
|
GO:0002009 |
333 |
0.028
|
|
|
stem cell proliferation
|
GO:0072089 |
4 |
0.028
|
|
|
liver development
|
GO:0001889 |
96 |
0.028
|
|
|
posterior lateral line nerve glial cell development
|
GO:0048941 |
5 |
0.028
|
|
|
regulation of neuron projection development
|
GO:0010975 |
40 |
0.027
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
1 |
0.027
|
|
|
neuroepithelial cell differentiation
|
GO:0060563 |
26 |
0.027
|
|
|
negative regulation of cellular metabolic process
|
GO:0031324 |
77 |
0.027
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
9 |
0.027
|
|
|
larval heart development
|
GO:0007508 |
2 |
0.027
|
|
|
organic acid catabolic process
|
GO:0016054 |
3 |
0.027
|
|
|
regulation of neurological system process
|
GO:0031644 |
2 |
0.027
|
|
|
negative regulation of rna biosynthetic process
|
GO:1902679 |
45 |
0.027
|
|
|
mapk cascade
|
GO:0000165 |
18 |
0.027
|
|
|
muscle structure development
|
GO:0061061 |
196 |
0.027
|
|
|
endochondral bone morphogenesis
|
GO:0060350 |
8 |
0.027
|
|
|
myelination of lateral line nerve axons
|
GO:0048897 |
5 |
0.027
|
|
|
chromatin organization
|
GO:0006325 |
22 |
0.026
|
|
|
regulation of extent of cell growth
|
GO:0061387 |
29 |
0.026
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
15 |
0.026
|
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
5 |
0.026
|
|
|
polarized epithelial cell differentiation
|
GO:0030859 |
4 |
0.026
|
|
|
diencephalon development
|
GO:0021536 |
58 |
0.026
|
|
|
signal transduction in absence of ligand
|
GO:0038034 |
1 |
0.026
|
|
|
growth plate cartilage development
|
GO:0003417 |
2 |
0.026
|
|
|
leukocyte proliferation
|
GO:0070661 |
1 |
0.026
|
|
|
phenol containing compound biosynthetic process
|
GO:0046189 |
4 |
0.026
|
|
|
leukocyte differentiation
|
GO:0002521 |
25 |
0.026
|
|
|
detection of stimulus
|
GO:0051606 |
29 |
0.025
|
|
|
larval development
|
GO:0002164 |
2 |
0.025
|
|
|
negative regulation of cell differentiation
|
GO:0045596 |
46 |
0.025
|
|
|
anterior lateral line nerve glial cell development
|
GO:0048939 |
3 |
0.025
|
|
|
blood circulation
|
GO:0008015 |
87 |
0.025
|
|
|
cellular response to stress
|
GO:0033554 |
62 |
0.025
|
|
|
regulation of dendrite development
|
GO:0050773 |
3 |
0.025
|
|
|
myelination of posterior lateral line nerve axons
|
GO:0048932 |
5 |
0.025
|
|
|
cell cycle g1 s phase transition
|
GO:0044843 |
1 |
0.024
|
|
|
cell killing
|
GO:0001906 |
2 |
0.024
|
|
|
cellular protein modification process
|
GO:0006464 |
100 |
0.024
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
2 |
0.024
|
|
|
neural tube patterning
|
GO:0021532 |
33 |
0.024
|
|
|
central nervous system neuron development
|
GO:0021954 |
29 |
0.023
|
|
|
peptidyl lysine acetylation
|
GO:0018394 |
2 |
0.023
|
|
|
kupffer s vesicle development
|
GO:0070121 |
50 |
0.023
|
|
|
posterior lateral line nerve glial cell morphogenesis involved in differentiation
|
GO:0048942 |
5 |
0.023
|
|
|
internal peptidyl lysine acetylation
|
GO:0018393 |
2 |
0.023
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
0 |
0.023
|
|
|
cellular component biogenesis
|
GO:0044085 |
178 |
0.022
|
|
|
regulation of intracellular signal transduction
|
GO:1902531 |
57 |
0.022
|
|
|
multicellular organismal signaling
|
GO:0035637 |
22 |
0.022
|
|
|
nuclear transport
|
GO:0051169 |
4 |
0.022
|
|
|
heart morphogenesis
|
GO:0003007 |
156 |
0.022
|
|
|
carbohydrate derivative metabolic process
|
GO:1901135 |
61 |
0.022
|
|
|
mechanoreceptor differentiation
|
GO:0042490 |
37 |
0.022
|
|
|
g1 s transition of mitotic cell cycle
|
GO:0000082 |
1 |
0.022
|
|
|
inner ear receptor cell fate commitment
|
GO:0060120 |
4 |
0.022
|
|
|
chromatin modification
|
GO:0016568 |
21 |
0.022
|
|
|
positive regulation of cell development
|
GO:0010720 |
25 |
0.022
|
|
|
abducens nucleus development
|
GO:0021742 |
2 |
0.022
|
|
|
regulation of reproductive process
|
GO:2000241 |
4 |
0.022
|
|
|
catechol containing compound metabolic process
|
GO:0009712 |
2 |
0.022
|
|
|
single organism behavior
|
GO:0044708 |
24 |
0.021
|
|
|
reproductive process
|
GO:0022414 |
40 |
0.021
|
|
|
somitogenesis
|
GO:0001756 |
87 |
0.021
|
|
|
segmentation
|
GO:0035282 |
97 |
0.021
|
|
|
phosphate containing compound metabolic process
|
GO:0006796 |
108 |
0.021
|
|
|
b cell activation
|
GO:0042113 |
2 |
0.021
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
11 |
0.021
|
|
|
positive regulation of multicellular organismal process
|
GO:0051240 |
52 |
0.021
|
|
|
regulation of epithelial to mesenchymal transition
|
GO:0010717 |
3 |
0.021
|
|
|
alcohol biosynthetic process
|
GO:0046165 |
2 |
0.021
|
|
|
single organism organelle organization
|
GO:1902589 |
199 |
0.021
|
|
|
negative regulation of apoptotic process
|
GO:0043066 |
55 |
0.020
|
|
|
regulation of embryonic development
|
GO:0045995 |
47 |
0.020
|
|
|
growth
|
GO:0040007 |
174 |
0.020
|
|
|
negative regulation of cellular biosynthetic process
|
GO:0031327 |
55 |
0.020
|
|
|
endochondral bone growth
|
GO:0003416 |
2 |
0.020
|
|
|
osteoclast development
|
GO:0036035 |
1 |
0.020
|
|
|
regulation of phosphate metabolic process
|
GO:0019220 |
43 |
0.020
|
|
|
mitotic cell cycle process
|
GO:1903047 |
48 |
0.020
|
|
|
protein acylation
|
GO:0043543 |
3 |
0.020
|
|
|
positive regulation of chromatin modification
|
GO:1903310 |
1 |
0.020
|
|
|
somite development
|
GO:0061053 |
96 |
0.020
|
|
|
positive regulation of macromolecule biosynthetic process
|
GO:0010557 |
59 |
0.019
|
|
|
cell fate specification involved in pattern specification
|
GO:0060573 |
3 |
0.019
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
216 |
0.019
|
|
|
compound eye development
|
GO:0048749 |
2 |
0.019
|
|
|
positive regulation of leukocyte differentiation
|
GO:1902107 |
1 |
0.018
|
|
|
sensory neuron axon guidance
|
GO:0097374 |
3 |
0.018
|
|
|
multicellular organismal reproductive process
|
GO:0048609 |
35 |
0.018
|
|
|
apical junction assembly
|
GO:0043297 |
1 |
0.018
|
|
|
neuronal action potential
|
GO:0019228 |
18 |
0.018
|
|
|
spinal cord association neuron differentiation
|
GO:0021527 |
1 |
0.018
|
|
|
glial cell development
|
GO:0021782 |
20 |
0.018
|
|
|
neurological system process
|
GO:0050877 |
62 |
0.018
|
|
|
positive regulation of cell differentiation
|
GO:0045597 |
30 |
0.018
|
|
|
regulation of molecular function
|
GO:0065009 |
70 |
0.018
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
5 |
0.018
|
|
|
lateral line nerve development
|
GO:0048892 |
9 |
0.018
|
|
|
cell cycle process
|
GO:0022402 |
53 |
0.017
|
|
|
chondrocyte intercalation involved in growth plate cartilage morphogenesis
|
GO:0003428 |
1 |
0.017
|
|
|
neuron projection extension
|
GO:1990138 |
45 |
0.017
|
|
|
response to abiotic stimulus
|
GO:0009628 |
122 |
0.017
|
|
|
autophagy
|
GO:0006914 |
4 |
0.017
|
|
|
cartilage development involved in endochondral bone morphogenesis
|
GO:0060351 |
8 |
0.017
|
|
|
t cell mediated immunity
|
GO:0002456 |
1 |
0.017
|
|
|
camera type eye morphogenesis
|
GO:0048593 |
108 |
0.017
|
|
|
protein complex subunit organization
|
GO:0071822 |
46 |
0.017
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
1 |
0.017
|
|
|
lipid storage
|
GO:0019915 |
1 |
0.017
|
|
|
regulation of cell development
|
GO:0060284 |
100 |
0.017
|
|
|
cellular process involved in reproduction in multicellular organism
|
GO:0022412 |
28 |
0.017
|
|
|
regulation of erk1 and erk2 cascade
|
GO:0070372 |
4 |
0.017
|
|
|
anterior lateral line nerve glial cell differentiation
|
GO:0048913 |
3 |
0.017
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
25 |
0.017
|
|
|
positive regulation of metabolic process
|
GO:0009893 |
108 |
0.017
|
|
|
nucleotide metabolic process
|
GO:0009117 |
28 |
0.017
|
|
|
pronephros development
|
GO:0048793 |
69 |
0.017
|
|
|
positive regulation of secretion
|
GO:0051047 |
1 |
0.017
|
|
|
lymphocyte proliferation
|
GO:0046651 |
1 |
0.017
|
|
|
developmental cell growth
|
GO:0048588 |
52 |
0.016
|
|
|
specification of symmetry
|
GO:0009799 |
204 |
0.016
|
|
|
auditory receptor cell fate determination
|
GO:0042668 |
2 |
0.016
|
|
|
protein localization
|
GO:0008104 |
40 |
0.016
|
|
|
medulla oblongata development
|
GO:0021550 |
4 |
0.016
|
|
|
nephron morphogenesis
|
GO:0072028 |
2 |
0.016
|
|
|
single organism transport
|
GO:0044765 |
206 |
0.016
|
|
|
thymus development
|
GO:0048538 |
10 |
0.016
|
|
|
spermatid development
|
GO:0007286 |
2 |
0.016
|
|
|
regulation of endodermal cell fate specification
|
GO:0042663 |
15 |
0.016
|
|
|
glucose transport
|
GO:0015758 |
6 |
0.016
|
|
|
neuron projection extension involved in neuron projection guidance
|
GO:1902284 |
10 |
0.016
|
|
|
sexual reproduction
|
GO:0019953 |
36 |
0.016
|
|
|
regulation of neural retina development
|
GO:0061074 |
2 |
0.016
|
|
|
carboxylic acid metabolic process
|
GO:0019752 |
22 |
0.016
|
|
|
renal system process involved in regulation of systemic arterial blood pressure
|
GO:0003071 |
1 |
0.016
|
|
|
positive regulation of axon extension involved in axon guidance
|
GO:0048842 |
1 |
0.015
|
|
|
osteoclast differentiation
|
GO:0030316 |
1 |
0.015
|
|
|
regulation of chromatin modification
|
GO:1903308 |
5 |
0.015
|
|
|
embryonic retina morphogenesis in camera type eye
|
GO:0060059 |
22 |
0.015
|
|
|
tissue regeneration
|
GO:0042246 |
74 |
0.015
|
|
|
developmental process involved in reproduction
|
GO:0003006 |
27 |
0.015
|
|
|
mesoderm development
|
GO:0007498 |
88 |
0.015
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
13 |
0.015
|
|
|
internal protein amino acid acetylation
|
GO:0006475 |
2 |
0.015
|
|
|
mononuclear cell proliferation
|
GO:0032943 |
1 |
0.015
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
1 |
0.015
|
|
|
regulation of localization
|
GO:0032879 |
104 |
0.015
|
|
|
response to wounding
|
GO:0009611 |
116 |
0.015
|
|
|
neural plate anterior posterior regionalization
|
GO:0021999 |
8 |
0.015
|
|
|
regulation of cell size
|
GO:0008361 |
29 |
0.015
|
|
|
myelination of anterior lateral line nerve axons
|
GO:0048914 |
3 |
0.015
|
|
|
cardiac chamber formation
|
GO:0003207 |
4 |
0.014
|
|